LONI10-12 characterization: 5, 161.5, 141.5, 137.9, 133.7, 133.4, 130.8, 129.5, 128.2, 127.7, 123.3, 122.5, 122.2, 110.9, 57.7, 50.1, 49.1, 31.5, 25.8, 19.6, 18.7 5, 160.7, 141.5, 137.7, 133.7, 133.5, 130.8, 129.5, 128.2, 127.7, 123.4, 122.4, 122.2, 110.1, 59.3, 49.1, 35.2, 26.9, 25.6 (S)-1-(2,4-dichlorobenzyl)-N-(4-methyl-1-(methylamino)-1-oxopentan-2-yl)-1H-indazole-3carboxamide (LONI12). Compound LONI7 was transformed in the N-methyl amide derivative LONI12 following the general procedure. The desired compound was obtained in quantitative yield, after reaction work up. Rt (analytical HPLC) = 26.50 min. 1 H NMR (300 MHz, DMSO-d6) δ 8.18 (d, 1H, H1), 8.04-7.95 (m, 2H, H4 and NH(CH3)), 7.73-7.70 (m, 2H, H-3 and NH amide), 7.46 (t, 1H, H2), 7.36-7.27 (m, 2H, H-2 and H3), 6.79 (d, 1H, H-1), 5.83 (s, 2H, -CH2-), 4.55 (q, 1H, CH α Leu), 2.57 (d, 3H, NH(CH3) Leu), 1.66-1.45 (m, 3H, CH2  Leu and CH  Leu), 0.87 (dd, 6H, CH3x2 Leu). 13 C NMR (300 MHz, DMSO-d6)  172. 6, 161.7, 141.4, 138.1, 133.8, 133.2, 130.7, 129.5, 128.2, 127.7, 123.2, 122.6, 122.3, 110.8, 51.2, 50.1, 49.1, 41.7, 26.1, 24.8, 23.3, 22. Figure 3S . System model used in the molecular dynamic simulation. S12 Figure 4S . Protein-ligand interactions of CB1 receptor with (A) MDMB-Fubinaca ligand, (B) LONI4 and (C) LONI11, calculated after 20 ns of MD. S13 Figure 5S . RMSD (angstroms) for ligand MDMB-Fubinaca (A), LONI4 (B) and LONI11 (C) and the receptor CB1 during 20 ns of molecular dynamic simulation.
